Collplant Biotechnologies Share Price Today
(NASDAQ: CLGN)

Name: Collplant Biotechnologies Share Price Today (NASDAQ: CLGN) - Collplant Biotechnologies Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Collplant Biotechnologies share price is $3.78 & ₹329.22 as on 5 Feb 2025, 2.30 'hrs' IST

$3.78

▲

0.05

(1.34%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Collplant Biotechnologies share price in Dollar and Rupees. Guide to invest in Collplant Biotechnologies stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Collplant Biotechnologies, along with analyst recommendations, forecasts, and comprehensive financials.

Collplant Biotechnologies share price movements

Today's Low: $3.62
Today's High: $4.00
$3.78
4.23%
Downside
Day's Volatility :9.5%
Upside
5.5%
52 Weeks Low: $3.24
52 Weeks High: $6.75
$3.78
14.29%
Downside
52 Weeks Volatility :52.0%
Upside
44.0%

Collplant Biotechnologies (CLGN) Returns

Period	Collplant Biotechnologies Ltd	Index (Russel 2000)
3 Months	-4.3%	0.0%
6 Months	-18.18%	0.0%
1 Year	-34.26%	0.0%
3 Years	-61.19%	-11.7%

Collplant Biotechnologies (CLGN) Key Statistics

in dollars & INR

Previous Close	$3.73
Open	$3.71
Today's High	$4.0
Today's Low	$3.62
Market Capitalization	$43.3M
Today's Volume	$10.1K
52 Week High	$6.75
52 Week Low	$3.24
Revenue TTM	$689.0K
EBITDA	$-17.3M
Earnings Per Share (EPS)	$-1.53
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-61.55%

How to invest in Collplant Biotechnologies Stock (CLGN) from India?

It is very easy for Indian residents to invest directly in Collplant Biotechnologies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Collplant Biotechnologies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Collplant Biotechnologies or CLGN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Collplant Biotechnologies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Collplant Biotechnologies shares which would translate to 0.230 fractional shares of Collplant Biotechnologies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Collplant Biotechnologies, in just a few clicks!

Returns in Collplant Biotechnologies (CLGN) for Indian investors in Rupees

The Collplant Biotechnologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Collplant Biotechnologies investment value today

Current value as on today

₹70,643

Returns

₹29,357

(-29.36%)

Returns from Collplant Biotechnologies Stock

₹34,261 (-34.26%)

Dollar Returns

₹4,903 (+4.9%)

Indian investors sentiment towards Collplant Biotechnologies (CLGN)

-46%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Collplant Biotechnologies Stock from India on INDmoney has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Collplant Biotechnologies

Parallel Advisors, LLC
0.03%

Analyst Recommendation on Collplant Biotechnologies

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Collplant Biotechnologies(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Collplant Biotechnologies Stock (CLGN)

What analysts predicted

Upside of 230.69%

Target:

$12.50

Current:

$3.78

Insights on Collplant Biotechnologies Stock (Ticker Symbol: CLGN)

Price Movement
In the last 6 months, CLGN stock has moved down by -19.6%
Decreasing Revenue
Revenue is down for the last 2 quarters, 249.0K → 4.0K (in $), with an average decrease of 98.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -4.19M → -4.32M (in $), with an average decrease of 1.6% per quarter
CLGN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.8% return, outperforming this stock by 92.5%
CLGN vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 86.4% return, outperforming this stock by 147.7%
Price to Sales
ForCLGN every $1 of sales, investors are willing to pay $63.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.4 for every $1 of sales.

CLGN Collplant Biotechnologies Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$4.8M	↑ 897.75%
Net Income	$-6.2M	↑ 3.27%
Net Profit Margin	-130.5%	↑ 1130.34%

	FY19	Y/Y Change
Revenue	$2.3M	↓ 51.59%
Net Income	$-14.7M	↑ 135.19%
Net Profit Margin	-634.04%	↓ 503.54%

	FY20	Y/Y Change
Revenue	$6.1M	↑ 164.75%
Net Income	$-5.8M	↓ 60.48%
Net Profit Margin	-94.64%	↑ 539.4%

	FY21	Y/Y Change
Revenue	$15.6M	↑ 154.86%
Net Income	$409.0K	↓ 107.04%
Net Profit Margin	2.61%	↑ 97.25%

	FY22	Y/Y Change
Revenue	$299.0K	↓ 98.09%
Net Income	$-16.8M	↓ 4196.09%
Net Profit Margin	-5.6K%	↓ 5605.62%

	FY23	Y/Y Change
Revenue	$11.0M	↑ 3565.22%
Net Income	$-7.0M	↓ 58.1%
Net Profit Margin	-64.05%	↑ 5538.96%

	Q2 FY23	Q/Q Change
Revenue	$10.2M	↑ 2251.96%
Net Income	$5.8M	↓ 247.33%
Net Profit Margin	56.58%	↑ 959.81%

	Q3 FY23	Q/Q Change
Revenue	$43.0K	↓ 99.58%
Net Income	$-4.4M	↓ 175.96%
Net Profit Margin	-10.2K%	↓ 10235.65%

	Q4 FY23	Q/Q Change
Revenue	$299.0K	↑ 595.35%
Net Income	$-4.7M	↑ 7.13%
Net Profit Margin	-1.6K%	↑ 8610.84%

	Q1 FY24	Q/Q Change
Revenue	$98.0K	↓ 67.22%
Net Income	$-4.2M	↓ 10.54%
Net Profit Margin	-4.3K%	↓ 2712.38%

	Q2 FY24	Q/Q Change
Revenue	$249.0K	↑ 154.08%
Net Income	$-4.2M	↑ 0.36%
Net Profit Margin	-1.7K%	↑ 2589.85%

	Q3 FY24	Q/Q Change
Revenue	$4.0K	↓ 98.39%
Net Income	$-4.3M	↑ 2.76%
Net Profit Margin	-108.2K%	↓ 106459.24%

	FY18	Y/Y Change
Profit	$4.4M	↑ 848.42%

	FY19	Y/Y Change
Profit	$439.0K	↓ 90.04%

	FY20	Y/Y Change
Profit	$3.1M	↑ 614.12%

	FY21	Y/Y Change
Profit	$13.6M	↑ 334.96%

	FY22	Y/Y Change
Profit	$-101.0K	↓ 100.74%

	FY23	Y/Y Change
Profit	$9.0M	↓ 8979.21%

	Q2 FY23	Q/Q Change
Profit	$9.6M	↑ 8760.19%

	Q3 FY23	Q/Q Change
Profit	$-235.0K	↓ 102.46%

	Q4 FY23	Q/Q Change
Profit	$-474.0K	↑ 101.7%

	Q1 FY24	Q/Q Change
Profit	$-727.0K	↑ 53.38%

	Q2 FY24	Q/Q Change
Profit	$-287.0K	↓ 60.52%

	Q3 FY24	Q/Q Change
Profit	$-268.0K	↓ 6.62%

	FY18	Y/Y Change
Operating Cash Flow	$-1.2M	↓ 75.93%
Investing Cash Flow	$-832.0K	↑ 555.12%
Financing Cash Flow	$2.6M	↓ 71.76%

	FY19	Y/Y Change
Operating Cash Flow	$-5.7M	↑ 360.42%
Investing Cash Flow	$-1.5M	↑ 75.6%
Financing Cash Flow	$5.4M	↑ 105.5%

	FY20	Y/Y Change
Operating Cash Flow	$-4.5M	↓ 21.95%
Investing Cash Flow	$-519.0K	↓ 64.48%
Financing Cash Flow	$4.5M	↓ 17.47%

	FY21	Y/Y Change
Operating Cash Flow	$2.5M	↓ 156.19%
Investing Cash Flow	$-31.6M	↑ 5980.15%
Financing Cash Flow	$38.8M	↑ 768.09%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-3.7M	↑ 8.52%
Investing Cash Flow	$-396.0K	↑ 0.0%
Financing Cash Flow	$89.0K	↓ 88.92%

Collplant Biotechnologies Technicals Summary

Sell

Neutral

Buy

Collplant Biotechnologies is currently in a neutral trading position according to technical analysis indicators.

Collplant Biotechnologies (CLGN) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Collplant Biotechnologies Ltd	-14.34%	-18.18%	-34.26%	-61.19%	-65.79%
Biontech Se	-2.55%	47.81%	22.02%	-32.21%	279.34%
Regeneron Pharmaceuticals, Inc.	-2.68%	-34.72%	-25.67%	12.0%	82.54%
Vertex Pharmaceuticals Incorporated	19.82%	3.52%	15.9%	98.26%	100.9%
Alnylam Pharmaceuticals, Inc.	16.23%	4.16%	57.39%	82.31%	115.97%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Collplant Biotechnologies Ltd	NA	NA	NA	0.0	-0.62	-0.34	NA	2.48
Biontech Se	160.8	NA	0.04	-3.37	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	16.49	16.49	1.08	44.92	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.48	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Collplant Biotechnologies Ltd	Buy	$43.3M	-65.79%	NA	0.0%
Biontech Se	Buy	$28.7B	279.34%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$73.3B	82.54%	16.49	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$121.1B	100.9%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$35.4B	115.97%	NA	-15.86%

About Collplant Biotechnologies

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.

Organization	Collplant Biotechnologies
Employees	75
CEO	Mr. Yehiel Tal
Industry	Health Technology

Management People of Collplant Biotechnologies

Name	Title
Mr. Yehiel Tal	CEO & Director
Mr. Eran Rotem CPA	Deputy CEO & CFO
Mr. Oren Fahimipoor	Vice President of Operations
Dr. Elana Gazal	Vice President of Research & Development
Prof. Oded Shoseyov	Founder & Chief Scientist
Ms. Hadas Dreiher Horowitz	Vice President of Human Resources

Important FAQs about investing in CLGN Stock from India :

What is Collplant Biotechnologies share price today?

Collplant Biotechnologies share price today stands at $3.78, Open: $3.71 ; Previous Close: $3.73 ; High: $4.00 ; Low: $3.62 ; 52 Week High: $6.75 ; 52 Week Low: $3.24.

The stock opens at $3.71, after a previous close of $3.73. The stock reached a daily high of $4.00 and a low of $3.62, with a 52-week high of $6.75 and a 52-week low of $3.24.

Can Indians buy Collplant Biotechnologies shares?

Yes, Indians can invest in the Collplant Biotechnologies (CLGN) from India.

With INDmoney, you can buy Collplant Biotechnologies at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Collplant Biotechnologies at zero transaction cost.

How can I buy Collplant Biotechnologies shares from India?

It is very easy to buy Collplant Biotechnologies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Collplant Biotechnologies (CLGN) be purchased?

Yes, you can buy fractional shares of Collplant Biotechnologies with INDmoney app.

What are the documents required to start investing in Collplant Biotechnologies stocks?

To start investing in Collplant Biotechnologies, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.